These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 21247263

  • 1. The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer.
    Zhang Z, Xu X, Zhang X, Chen X, Chen Q, Dong L, Hu Z, Li J, Gao J.
    Acta Oncol; 2011 Oct; 50(7):1111-8. PubMed ID: 21247263
    [Abstract] [Full Text] [Related]

  • 2. [Immobilization of streptavidin-tagged bioactive hTNF-alpha on biotinylated mucosal surface of the bladder wall for treatment of superficial bladder cancer in mice].
    Chen Z, Tan WL, Huang X, Liang ZK, Xu CX, Gao JM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):936-40. PubMed ID: 20501361
    [Abstract] [Full Text] [Related]

  • 3. [Intravesical anchoring of streptavidin-tagged interleukin-4 fusion protein for immunotherapy of mouse superficial bladder cancer].
    Zhang Z, Xu XL, Ma L, Li JL, Hu ZM, Gao JM.
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):331-5. PubMed ID: 22883451
    [Abstract] [Full Text] [Related]

  • 4. A novel immunotherapy for superficial bladder cancer by the immobilization of streptavidin-tagged bioactive IL-2 on the biotinylated mucosal surface of the bladder wall.
    Huang X, Yu HS, Chen Z, Li JL, Hu ZM, Gao JM.
    Chin J Cancer; 2010 Jun; 29(6):611-6. PubMed ID: 20507734
    [Abstract] [Full Text] [Related]

  • 5. A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF.
    Hu Z, Tan W, Zhang L, Liang Z, Xu C, Su H, Lu J, Gao J.
    J Cell Mol Med; 2010 Jun; 14(6B):1836-44. PubMed ID: 19627402
    [Abstract] [Full Text] [Related]

  • 6. A novel therapeutic vaccine of mouse GM-CSF surface modified MB49 cells against metastatic bladder cancer.
    Zhang X, Shi X, Li J, Hu Z, Zhou D, Gao J, Tan W.
    J Urol; 2012 Mar; 187(3):1071-9. PubMed ID: 22266013
    [Abstract] [Full Text] [Related]

  • 7. Novel immunotherapy for metastatic bladder cancer using vaccine of human interleukin-2 surface-modified MB 49 cells.
    Zhang X, Shi X, Li J, Hu Z, Guo F, Huang X, Zhang Z, Sun P, Jing Y, Gao J, Tan W.
    Urology; 2011 Sep; 78(3):722.e1-722.e6. PubMed ID: 21741685
    [Abstract] [Full Text] [Related]

  • 8. Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer.
    Sänger C, Busche A, Bentien G, Spallek R, Jonas F, Böhle A, Singh M, Brandau S.
    BMC Cancer; 2004 Nov 26; 4():86. PubMed ID: 15566565
    [Abstract] [Full Text] [Related]

  • 9. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
    Wu Q, Mahendran R, Esuvaranathan K.
    Clin Cancer Res; 2003 Oct 01; 9(12):4522-8. PubMed ID: 14555526
    [Abstract] [Full Text] [Related]

  • 10. [Expression, purification and refolding of streptavidin-tagged human tumor necrosis factor-alpha fusion protein].
    Xu CX, Hu ZM, Li JL, Gao JM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar 01; 29(3):412-5. PubMed ID: 19304513
    [Abstract] [Full Text] [Related]

  • 11. Local AdCD40L gene therapy is effective for disseminated murine experimental cancer by breaking T-cell tolerance and inducing tumor cell growth inhibition.
    Lindqvist C, Sandin LC, Fransson M, Loskog A.
    J Immunother; 2009 Oct 01; 32(8):785-92. PubMed ID: 19752755
    [Abstract] [Full Text] [Related]

  • 12. Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer.
    Shi X, Zhang X, Li J, Guo F, Hu Z, Jing Y, Bai L, Chen S, Wan P, Wang F, Gao J, Tan W.
    Urol Oncol; 2013 Aug 01; 31(6):883-93. PubMed ID: 21924648
    [Abstract] [Full Text] [Related]

  • 13. CpG oligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immunity in murine bladder cancer.
    Ninalga C, Loskog A, Klevenfeldt M, Essand M, Tötterman TH.
    J Immunother; 2005 Aug 01; 28(1):20-7. PubMed ID: 15614041
    [Abstract] [Full Text] [Related]

  • 14. Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49).
    Günther JH, Frambach M, Deinert I, Brandau S, Jocham D, Böhle A.
    J Urol; 1999 May 01; 161(5):1702-6. PubMed ID: 10210443
    [Abstract] [Full Text] [Related]

  • 15. A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity.
    Singh NP, Yolcu ES, Taylor DD, Gercel-Taylor C, Metzinger DS, Dreisbach SK, Shirwan H.
    Cancer Res; 2003 Jul 15; 63(14):4067-73. PubMed ID: 12874008
    [Abstract] [Full Text] [Related]

  • 16. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
    Mangsbo SM, Ninalga C, Essand M, Loskog A, Tötterman TH.
    J Immunother; 2008 Jan 15; 31(1):34-42. PubMed ID: 18157010
    [Abstract] [Full Text] [Related]

  • 17. New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin.
    Kawano H, Komaba S, Yamasaki T, Maeda M, Kimura Y, Maeda A, Kaneda Y.
    Cancer Chemother Pharmacol; 2008 May 15; 61(6):973-8. PubMed ID: 17653716
    [Abstract] [Full Text] [Related]

  • 18. [Preparation and bioactivity evaluation of SA-mIL15 fusing protein].
    Chen YL, Xu XL, Tang J, Nie XX, Song ZC, Hu ZM, Gao JM.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb 15; 26(2):107-10. PubMed ID: 20230665
    [Abstract] [Full Text] [Related]

  • 19. Antitumor immunity against bladder cancer induced by ex vivo expression of CD40 ligand gene using retrovirus vector.
    Kimura T, Ohashi T, Kikuchi T, Kiyota H, Eto Y, Ohishi Y.
    Cancer Gene Ther; 2003 Nov 15; 10(11):833-9. PubMed ID: 14605669
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: dose dependent tumor eradication and generation of protective immunity.
    O'Donnell MA, Luo Y, Hunter SE, Chen X, Hayes LL, Clinton SK.
    J Urol; 2004 Mar 15; 171(3):1330-5. PubMed ID: 14767343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.